Science Explorer Back to mapMap
Discussion
Topic · Emergency Medicine

Hematological disorders and diagnostics

Hematological disorders and diagnostics is a research topic within Emergency Medicine. Science Explorer counts 28k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnostic approach to fever of unknown origin (FUO), with a particular emphasis on the use of FDG PET/CT imaging, bone marrow biopsy, and the evaluation of pancytopenia. It encompasses studies on the clinical evaluation, etiological profile, and diagnostic algorithms for identifying the cause of FUO, often related to inflammation and hematological malignancies. The cluster includes numerous prospective studies, meta-analyses, and systematic reviews highlighting the importance of these diagnostic tools in managing patients with FUO.

  • FDG PET/CT
  • Bone Marrow Biopsy
  • Pancytopenia
  • Inflammation
  • Diagnostic Algorithm
  • Etiological Profile
  • Hematological Malignancy
  • Clinical Evaluation
  • Meta-Analysis
  • Prospective Study
Research works
28k
fractional, since 1950
In the world top 10%
2.9k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-2%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Hematological disorders and diagnostics

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Hematological disorders and diagnostics research?

By volume, the United States and India publish the most (861 and 522 works in 2022-now).

By volume, 2022-now

  1. 1 United States 861 works
  2. 2 India 522 works
  3. 3 China 457 works
  4. 4 Germany 187 works
  5. 5 United Kingdom 167 works
  6. 6 Japan 163 works
  7. 7 Türkiye 142 works
  8. 8 Spain 123 works
  9. 9 Italy 122 works
  10. 10 Brazil 115 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.1%India: 18.2%China: 16.0%Germany: 6.5%6 others listed: 29.1%30%largest
United States861 · 30.1%India522 · 18.2%China457 · 16.0%Germany187 · 6.5%6 others listed832 · 29.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Hematological disorders and diagnostics research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Hematological disorders and diagnostics research, followed by Harvard University and Mayo Clinic.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 44 works
  2. 2 Harvard UniversityUnited States 30 works
  3. 3 Mayo ClinicUnited States 24 works
  4. 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 23 works
  5. 5 Post Graduate Institute of Medical Education and ResearchIndia 18 works
  6. 6 The University of Texas MD Anderson Cancer CenterUnited States 16 works
  7. 7 Johns Hopkins UniversityUnited States 15 works
  8. 8 Banaras Hindu UniversityIndia 15 works
  9. 9 Peking UniversityChina 14 works
  10. 10 Tel Aviv UniversityIsrael 13 works

Who are the leading researchers in Hematological disorders and diagnostics?

The most-cited researchers publishing on Hematological disorders and diagnostics include Simon Iain Hay, Gad A. Getz and Elaine R. Mardis.

  1. 1 Simon Iain Hay United States 452k citations
  2. 2 Gad A. Getz United States 364k citations
  3. 3 Elaine R. Mardis United States 346k citations
  4. 4 Shizuo Akira Japan 342k citations
  5. 5 Cyrus Cooper United Kingdom 342k citations
  6. 6 Gordon Henry Guyatt Canada 315k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Hematological disorders and diagnostics?

The most cited paper in Hematological disorders and diagnostics is "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia" (Daniel A. Arber, Attilio Orazi, Robert Paul Hasserjian et al., 2016), with 10,371 citations. Next come "Proposals for the Classification of the Acute Leukaemias F rench ‐A merican ‐B ritish (FAB) C o‐operative G roup" (5,633) and "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes" (4,457).

Most cited papers
#PaperReleasedCitations
1 The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Daniel A. Arber, Attilio Orazi, Robert Paul Hasserjian et al. · Blood Open access 12 Apr 2016 10,371
2 Proposals for the Classification of the Acute Leukaemias F rench ‐A merican ‐B ritish (FAB) C o‐operative G roup John M. Bennett, Daniel Catovsky, Marie‐Theregse Daniel et al. · British Journal of Haematology Aug 1976 5,633
3 The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes James W. Vardiman, Jüergen Thiele, Daniel A. Arber et al. · Blood Open access 9 Apr 2009 4,457
4 Mesenchymal and haematopoietic stem cells form a unique bone marrow niche Simón Méndez‐Ferrer, Tatyana V. Michurina, Francesca Ferraro et al. · Nature Open access Aug 2010 3,419
5 Revised International Prognostic Scoring System for Myelodysplastic Syndromes Peter L. Greenberg et al. · Blood Open access 28 Jun 2012 3,195
All 100 most cited papers, with filters and sorting

Where is Hematological disorders and diagnostics research done?

The largest centres of Hematological disorders and diagnostics research in 2022-now are Beijing (China), London (United Kingdom), New Delhi (India) and Istanbul (Türkiye).

Largest cities, 2022-now

  1. 1 BeijingChina 72 works
  2. 2 LondonUnited Kingdom 52 works
  3. 3 New DelhiIndia 49 works
  4. 4 IstanbulTürkiye 40 works
  5. 5 ParisFrance 39 works
  6. 6 New YorkUnited States 38 works
  7. 7 TokyoJapan 38 works
  8. 8 MadridSpain 34 works
  9. 9 HoustonUnited States 31 works
  10. 10 BostonUnited States 29 works
See Hematological disorders and diagnostics on the map

Where is the best place to study Hematological disorders and diagnostics?

Among universities, judged by research, Harvard University, Johns Hopkins University and Huazhong University of Science and Technology score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 21.89%fractional works in this field (log) →share of work in the world top 10% →Johns Hopkins Univer…Huazhong University …Anhui Medical Univer…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 68.722.6%2.5×30 -22.1%
2Johns Hopkins UniversityUnited States 67.930.5%2.5×15 +12.4%
3Huazhong University of Science and TechnologyChina 57.630.1%1.8×12 +12.9%
4Anhui Medical UniversityChina 55.827.1%5.2×9 +44.5%
5Zhejiang UniversityChina 54.326.0%1.0×10 +67.8%
6All India Institute of Medical SciencesIndia 54.13.5%10.6×44 +32.5%
7Nanjing Medical UniversityChina 52.823.1%3.4×11 +41.7%
8Tel Aviv UniversityIsrael 50.617.6%4.5×13 -1.7%
9Stanford UniversityUnited States 45.717.3%2.0×11 -2.5%
10Capital Medical UniversityChina 45.521.1%3.0×12 +13.7%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Hematological disorders and diagnostics, country by country

Is Hematological disorders and diagnostics research growing?

Output in 2022-2025 was 2% lower than in 2018-2021, peaking in 2021.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Hematological disorders and diagnostics as a percentage of every work published that year, 0.017% in 2024.

still counting0.025%0.050%0.075%Hematological disorders and diagnostics0.017% in 202519801990200020102020

Fractional works of Hematological disorders and diagnostics over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Hematological disorders and diagnostics10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Hematological disorders and diagnostics. Posts are plain text and can be reported.